✦ LIBER ✦

An open-labeled, multicentered, observational study for the tolerability of Rivastigmine Transdermal Patch for Korean patients with Alzheimer's disease

✍ Scribed by Hae Ri Na; Sangyun Kim; Dong-Won Yang; Moon Ho Park; Sang Seok Kim; Jung Seok Lee; Youngsoon Yang; Hyun-Duk Yang; Jun-Seong Lim; YoungHee Chang

Book ID: 118466759
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 42 KB
Volume: 6
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.05.992

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label trial of Korean red ginsen

An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease

✍ J.-H. Heo; S.-T. Lee; K. Chu; M. J. Oh; H.-J. Park; J.-Y. Shim; M. Kim 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Open label, multicenter, 28-week extensi

Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB

Solanezumab was safe and well-tolerated

Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study

✍ Taro Goto; Shinji Fujikoshi; Kazunori Uenaka; Shinichi Nishiuma; Eric R. Siemers 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Memantine effects measured with the Rele

Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study

✍ Vjera Holthoff; Steven Ferris; Serge Gauthier; Ralf Ihl; Philippe Robert; Bengt 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Multicenter, open-label, dose-area escal

Multicenter, open-label, dose-area escalation, cohort study to evaluate the safety and tolerability of PEP005 (ingenol mebutate) gel 0.05% applied for two consecutive days to treatment area(s) of up to a total of 100cm2 in patients with actinic keratoses

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB